The Maui News

Biden transition

President elect seeks workaround

- By STEVE PEOPLES, DEB RIECHMANN and ZEKE MILLER

WILMINGTON, Del. — President Donald Trump’s refusal to cooperate with his successor is forcing Presidente­lect Joe Biden to seek unusual workaround­s to prepare for the exploding public health threat and evolving national security challenges he will inherit in just nine weeks.

Blocked from the official intelligen­ce briefing traditiona­lly afforded to incoming presidents, Biden gathered virtually on Tuesday with a collection of intelligen­ce, defense and diplomatic experts. None of the experts are currently affiliated with the U.S. government, raising questions about whether Biden is being provided the most up-to-date informatio­n about dangers facing the nation.

Vice President-elect Kamala Harris received a more formal briefing on Tuesday as a member of the Senate Intelligen­ce Committee, though still has relatively limited informatio­n about the specific threats Biden will inherit.

And as the worst pandemic in a century bears down on the U.S. with renewed ferocity, the current administra­tion is blocking Biden from collaborat­ing with its response team. Biden’s representa­tives instead plan to meet directly with pharmaceut­ical companies this week to determine how best to distribute at least two promising vaccines to hundreds of millions of Americans, the biggest logistical challenge to face a new president in generation­s.

The moves reflect how Biden is adjusting to a historical­ly tense transition. With no sign that Trump is prepared to facilitate soon a peaceful transfer of power, Biden and his team are instead working through a series of backup options to do the best they can to prepare for the challenges he will face as soon as he takes office in January.

Declining to criticize Trump, Biden acknowledg­ed Tuesday that he has “not been receiving briefings that would ordinarily come by now” as he opened his virtual meeting with the national security experts. The 12 participan­ts, who appeared on video screens, included former Deputy CIA Director David Cohen, retired Gen. Stanley McChrystal and Avril Haines, a deputy national security adviser in the Obama administra­tion, among others.

Biden said he was preparing to inherit “a divided country and a world in disarray.”

“That’s why I need you all,” he said.

Two weeks after the election, Trump continues to block Biden’s access to his administra­tion’s pandemic and national security briefings, falsely claiming that Biden is not the legitimate president-elect because of non-existent voter fraud. The Democrat defeated the Republican president 10 days ago, and Trump’s flailing legal strategy to block the certificat­ion of the election results is quickly fizzling out.

A study released on Tuesday by the Center for Presidenti­al Transition at the nonpartisa­n Partnershi­p for Public Service warned that an abbreviate­d transition could impair Biden’s ability to fill the more than 1,200 administra­tion jobs requiring Senate confirmati­on, including key Cabinet and subCabinet posts on the front lines of addressing the pandemic.

A growing group of Republican­s have begun to state publicly what Trump will not: Biden will become the next president on Jan. 20. Even Israeli Prime Minister Benjamin Netanyahu, a staunch Trump ally, referred to Biden as the American “president-elect” for the first time Tuesday.

“He isn’t getting the briefings that the president-elect should be getting, but that’s not going to stop him from doing everything he can to prepare and execute during this transition period,” said Biden transition spokesman T.J. Ducklo.

Trump’s decision to block the transfer of power has forced Biden to navigate the life-and-death business of vaccine distributi­on with limited informatio­n.

Biden’s team plans to meet with private pharmaceut­ical companies on its own in the coming days to learn more about the status of their vaccine production. While neither of the two most promising vaccines has yet earned U.S. government approval, they would almost certainly be distribute­d under Biden’s watch if and when they are formally deemed safe.

Currently under the Trump administra­tion, the Department of Health and Human Services and the Pentagon are working in conjunctio­n with states on a vaccine distributi­on plan. But the Biden transition team and Democrats in Congress also have ideas. There could be conflictin­g expectatio­ns for state leaders and health care systems, which will be closest to the actual work of putting shots into the arms of Americans.

Biden warned on Monday that “more people may die” if Trump continues to block his access to vaccine distributi­on plans and pandemic data.

 ??  ??
 ?? AP photo ?? President-elect Joe Biden attends a national security briefing at The Queen theater Tuesday in Wilmington, Del.
AP photo President-elect Joe Biden attends a national security briefing at The Queen theater Tuesday in Wilmington, Del.

Newspapers in English

Newspapers from United States